Yahoo News provides the latest updates on the spread of bird flu in the U.S. and its effect on rising egg prices and ...

Capital expenditures were $27 million in the fourth quarter of 2024, compared to $38 million in the fourth quarter of 2023. Revenue was $2,737 million in 2024, a decrease of 7% on a reported basis and ...

Marketplace revenue grew 15% YoYQ4’24 International revenue grew 26% YoY and OEM Advertising revenue grew double-digit YoYQ4'24 ...

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.

Commenced commercial production of NdPr metal at Independence Began trial production of automotive-grade magnets Achieved record production of ...